{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:32:09Z","timestamp":1793035929834,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministry of Science and Higher Education Poland","doi-asserted-by":"publisher","award":["K\/DSC\/004307"],"award-info":[{"award-number":["K\/DSC\/004307"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministry of Science and Higher Education Poland","doi-asserted-by":"publisher","award":["K\/ZDS\/005487"],"award-info":[{"award-number":["K\/ZDS\/005487"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministry of Science and Higher Education Poland","doi-asserted-by":"publisher","award":["K\/ZDS\/006235"],"award-info":[{"award-number":["K\/ZDS\/006235"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.bmc.2018.04.038","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T22:49:15Z","timestamp":1524005355000},"page":"3773-3784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Design, synthesis and cardiovascular evaluation of some aminoisopropanoloxy derivatives of xanthone"],"prefix":"10.1016","volume":"26","author":[{"given":"M.","family":"Kubacka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Szkaradek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mogilski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pa\u0144czyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Siwek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Grybo\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Filipek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"\u017bmudzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Marona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Waszkielewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2018.04.038_b0005","first-page":"718","article-title":"Xanthone derivatives with centrally stimulating and analeptic activities","volume":"18","author":"Da Re","year":"1968","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.bmc.2018.04.038_b0010","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1021\/jm00280a010","article-title":"Xanthone-2-carboxylic acids, a new series of antiallergic substances","volume":"15","author":"Pfister","year":"1972","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.04.038_b0015","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.bmcl.2016.12.045","article-title":"Structure\u2013activity relationships of diverse xanthones against multidrug resistant human tumor cells","volume":"27","author":"Wang","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2018.04.038_b0020","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1016\/j.bmc.2016.07.020","article-title":"Synthesis and anticancer potential of novel xanthone derivatives with 3,6-substituted chains","volume":"24","author":"Liu","year":"2016","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.bmc.2018.04.038_b0025","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1016\/j.bmc.2010.07.044","article-title":"2,3-Diarylxanthones as strong scavengers of reactive oxygen and nitrogen species: A structure-activity relationship study","volume":"18","author":"Santos","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2018.04.038_b0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/(SICI)1521-4184(199805)331:5<193::AID-ARDP193>3.0.CO;2-S","article-title":"Frahm a W. Substituted xanthones as antimycobacterial agents, Part 2: Antimycobacterial activity","volume":"331","author":"Pickert","year":"1998","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.bmc.2018.04.038_b0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/AAC.46.1.144-150.2002","article-title":"Optimization of Xanthones for Antimalarial Activity : the 3, 6-Bis-Diethylaminoalkoxyxanthone Series","volume":"46","author":"Kelly","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2018.04.038_b0040","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0968-0896(01)00315-7","article-title":"Antihypertensive and vasorelaxing activities of synthetic xanthone derivatives","volume":"10","author":"Wang","year":"2002","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2018.04.038_b0045","first-page":"21","article-title":"Synthesis and antimycobacterial assay of some xanthone derivatives","volume":"65","author":"Szkaradek","year":"2008","journal-title":"Acta Pol Pharm"},{"key":"10.1016\/j.bmc.2018.04.038_b0050","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.bmc.2012.12.051","article-title":"Anticonvulsant evaluation of aminoalkanol derivatives of 2- and 4-methylxanthone","volume":"21","author":"Szkaradek","year":"2013","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.bmc.2018.04.038_b0055","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ja.2016.36","article-title":"Anti-Helicobacter pylori activity of some newly synthesized derivatives of xanthone","volume":"69","author":"Klesiewicz","year":"2016","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.bmc.2018.04.038_b0060","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2174\/1871520616666160404110323","article-title":"Synthesis and in vitro evaluation of anticancer potential of new aminoalkanol derivatives of xanthone","volume":"16","author":"Szkaradek","year":"2016","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.bmc.2018.04.038_b0065","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.bmc.2012.11.014","article-title":"Synthesis and preliminary evaluation of pharmacological properties of some piperazine derivatives of xanthone","volume":"21","author":"Szkaradek","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2018.04.038_b0070","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00210-014-0983-3","article-title":"MH-3: Evidence for non-competitive antagonism towards the low-affinity site of \u03b21-adrenoceptors","volume":"387","author":"Schlicker","year":"2014","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.bmc.2018.04.038_b0075","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1016\/j.bmc.2015.09.005","article-title":"Cardiovascular activity of the chiral xanthone derivatives","volume":"23","author":"Szkaradek","year":"2015","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.bmc.2018.04.038_b0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejmech.2017.03.068","article-title":"Synthesis of xanthone derivatives and studies on the inhibition against cancer cells growth and synergistic combinations of them","volume":"133","author":"Liu","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2018.04.038_b0085","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ardp.200700156","article-title":"Synthesis and evaluation of some xanthone derivatives for anti-arrhythmic, hypotensive properties and their affinity for adrenergic receptors","volume":"341","author":"Marona","year":"2008","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.bmc.2018.04.038_b0090","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1021\/jm00278a029","article-title":"\u0392-Adrenergic blocking agents of the chromone and xanthone groups. II. Propanolol type derivatives","volume":"115","author":"Da Re","year":"1972","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.04.038_b0095","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1021\/jm00273a013","article-title":"\u0392-Adrenergic blocking agents. 12. Heterocyclic compounds related to propranolol","volume":"15","author":"Crowther","year":"1972","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.04.038_b0100","first-page":"733","article-title":"Synthesis, \u03b1-adrenoceptors affinity and \u03b1 1- adrenoceptor antagonistic properties of some 1,4-substituted piperazine derivatives","volume":"66","author":"Marona","year":"2011","journal-title":"Pharmazie"},{"key":"10.1016\/j.bmc.2018.04.038_b0105","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1476-5381.1996.tb16039.x","article-title":"The effect of S- (+) -boldine guinea-pig aorta on the alpha1-adrenoceptor of the guinea-pig aorta","volume":"119","author":"Chulia","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2018.04.038_b0110","first-page":"48","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2018.04.038_b0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1472-8206.2002.00081.x","article-title":"In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity","volume":"16","author":"De Clerck","year":"2002","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.bmc.2018.04.038_b0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmc.2018.04.038_b0125","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.bjp.0704450","article-title":"Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium","volume":"135","author":"Lowe","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2018.04.038_b0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejphar.2014.05.032","article-title":"Antiarrhythmic activity of some xanthone derivatives with \u03b21-adrenoceptor affinities in rats","volume":"738","author":"Rapacz","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2018.04.038_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2016.00229","article-title":"Chemically homogenous compounds with antagonistic properties at all \u03b11-adrenoceptor subtypes but not \u03b21-adrenoceptor attenuate adrenaline-induced arrhythmia in rats","volume":"7","author":"Pytka","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2018.04.038_b0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejphar.2013.10.021","article-title":"Antiarrhythmic properties of some1,4-disubstituted piperazine derivatives with \u03b11 -adrenoceptor affinities","volume":"720","author":"Kubacka","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2018.04.038_b0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejphar.2012.10.025","article-title":"The hypotensive activity and alpha1-adrenoceptor antagonistic properties of some aroxyalkyl derivatives of 2-methoxyphenylpiperazine","volume":"698","author":"Kubacka","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2018.04.038_b0150","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.phrs.2017.07.026","article-title":"Antihypertensive drugs","volume":"124","author":"Laurent","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bmc.2018.04.038_b0155","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/080370501753400665","article-title":"Beta-adrenergic blocking drugs in the treatment of hypertension","volume":"10","author":"Prichard","year":"2001","journal-title":"Blood Press"},{"key":"10.1016\/j.bmc.2018.04.038_b0160","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.amjcard.2010.08.023","article-title":"Beta-blockers in hypertension","volume":"106","author":"Ram","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.bmc.2018.04.038_b0165","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2796.2009.02140.x","article-title":"Cardioprotection with beta-blockers: Myths, facts and Pascal\u2019s wager","volume":"266","author":"Messerli","year":"2009","journal-title":"J Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.bmc.2018.04.038_b0170","first-page":"18","article-title":"Carvedilol: beta-blockade and beyond","volume":"5","author":"Stroe","year":"2004","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.bmc.2018.04.038_b0175","first-page":"1","article-title":"Mouse ECG findings in aging, with conduction system affecting drugs and in cardiac pathologies: Development and validation of ECG analysis algorithm in mice","volume":"3","author":"Merentie","year":"2015","journal-title":"Phys Rep"},{"key":"10.1016\/j.bmc.2018.04.038_b0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ardp.200800002","article-title":"Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives","volume":"342","author":"Lin","year":"2009","journal-title":"Arch Pharm (Weinheim)"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089617321867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089617321867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:54:14Z","timestamp":1760835254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089617321867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":36,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0968089617321867"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2018.04.038","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and cardiovascular evaluation of some aminoisopropanoloxy derivatives of xanthone","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2018.04.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}